Ascendis Pharma A/S Announces U.S. Commercial Launch of SKYTROFA® (Lonapegsomatropin-tcgd), the First and Only FDA Approved Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Asianada, Inc. (NASDAQ: ASND) | Delayed: 257.93 +7.76 (3.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $250.17 | 52 Week High | $21.79 | |||
| Open | $252.50 | 52 Week Low | $11.92 | |||
| Day High | $258.16 | P/E | N/A | |||
| Day Low | $248.31 | EPS | $-0.07 | |||
| Volume | 655,805 | |||||
